KLLN and cancer: Our results with the XTEN-fused Killin fragment presented in this study, which bears a cell-penetrating peptide and enzyme-specific cleavage site, is able to arrest cancer cell growth and induce apoptosis in vitro, while normal liver cells and cells without MMP-2 expression are almost unaffected.